Diagnos Laboratorium Utama Tbk. vs Multi Makmur Lemindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Multi Makmur Lemindo Tbk. trades at Rp125 (market cap 421.41B, 31.51M 24h volume). The key difference: Multi Makmur Lemindo Tbk. is the larger of the two by market cap, and Multi Makmur Lemindo Tbk. is more actively traded (31.51M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | PIPA | |
|---|---|---|
Market Cap | 310.75B | 421.41B |
Volume | 963.6K | 31.51M |
Lot | 9.64K | 315.07K |
Turnover | 217.67M | 3.94B |
Average Price | 225.89 | 125.2 |
Value | 217.67M | 3.94B |
Indicative Equilibrium Price | 226 | 125 |
Indicative Equilibrium Volume | 1K | 6.99K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Multi Makmur Lemindo Tbk (the Company) was established based on Notarial Deed No. 66 dated January 11, 2012 of Deni Nugraha, S.E., S.H., M.Kn., notary in Tangerang. The Company started its commercial operations in 2005.
Read more on PIPA →